Nurse Practitioner in Farwell, TX Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Sharleen Gammon, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 405 Avenue A, Farwell, TX 79325 Phone: 806-481-7000 Fax: 806-481-1006 |
Lacey Dawn Meeks, MSN, ACNP-BC, FNP-BC Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 405 Avenue A, Farwell, TX 79325 Phone: 806-481-7000 Fax: 806-481-1006 |
Jessica Simpson, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 405 Avenue A, Farwell, TX 79325 Phone: 806-481-7000 Fax: 806-481-1006 |
News Archive
Researchers turn their attention to Chagas disease as developed countries see rise in infection rates
Chagas disease, a historically neglected tropical disease that the WHO estimates affects about 10 million people worldwide, is drawing increased attention as infection by the parasite spreads from Latin America to developed countries, such as Spain and the United States, Science reports.
SDBJ names A-Life Medical executive as the CFO of the Year
A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding products and services to the healthcare industry, announced today that Jaye Connolly, who serves as chief financial officer and chief operating officer, has been named CFO of the Year in the private company category of the 2009 San Diego Business Journal (SDBJ) CFO of the Year awards program.
MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020
Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight immunotherapy advances being presented by researchers from The University of Texas MD Anderson Cancer Center at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting & Pre-Conference Programs.
New tools can help manage negative behavioural symptoms in dementia patients
A rapidly aging population means an increased likelihood of the diseases of old age becoming more prevalent and more problematic for those afflicted with such illnesses, their family and carers, and overburdened healthcare services.
Merck reports results from Phase 2b study of investigational house dust mite sublingual immunotherapy tablet
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
› Verified 6 days ago